ArticleThe Journal of urology2020
Re: Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a De Novo Low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer.
Samir S TanejaPubMed ↗Publisher ↗
No numbers read from the abstract.